World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02881411
Date of registration: 10/08/2016
Prospective Registration: No
Primary sponsor: University of the West of England
Public title: Self Soft Tissue Therapy for Fibromyalgia Syndrome
Scientific title: Self Soft Tissue Therapy for Fibromyalgia Syndrome; Randomised Controlled Feasibility Study
Date of first enrolment: July 2016
Target sample size: 20
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02881411
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
United Kingdom
Contacts
Name:     Rob M Grieve, PhD
Address: 
Telephone:
Email:
Affiliation:  University of the West of England
Key inclusion & exclusion criteria

Inclusion Criteria:

Aged over 18. Able be seated or lie prone for 30 minutes. Diagnosis or presentation of FMS
and attending FMS coping skills programme. Complaint of forearm/hand or lower leg/foot pain
or tenderness for the past 7 days..

No disorder apart from FMS, that would otherwise explain the pain or tenderness..

Exclusion criteria:

Complex regional pain syndrome. Talipes equino varus, triple arthrodesis. Bony block of the
ankle. Lower leg/foot injury. Forearm/hand injury. Diabetes. Peripheral vascular disease.
Cancer. Rheumatoid arthritis or neurological impairment. Receiving physiotherapy or MTrP
therapy to the upper or lower limb within the previous three months.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Fibromyalgia Syndrome
Intervention(s)
Other: Self-soft tissue therapy
Other: Fibromyalgia coping skills programme
Primary Outcome(s)
Pressure Pain Threshold (PPT)-Change is being assessed. [Time Frame: Baseline day 0, conclusion at 6 weeks and three months after conclusion]
Secondary Outcome(s)
Verbal Numerical Rating Scale-Verbal description of pain from 0-10-Change is being assessed [Time Frame: Baseline day 0, conclusion at 6 weeks and three months after conclusion]
Range of Movement (ROM)-Change is being assessed. [Time Frame: Baseline day 0, conclusion at 6 weeks and three months after conclusion]
Disabilities of Arm, Shoulder and Hand (DASH)-30-item, self-report questionnaire- Change is being assessed. [Time Frame: Baseline day 0, conclusion at 6 weeks and three months after conclusion]
Lower Extremity Functional Scale (LEFS)-self-reported questionnaire (0-80 points)-Change is being assessed [Time Frame: Baseline day 0, conclusion at 6 weeks and three months after conclusion]
Secondary ID(s)
JMA/It
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Royal United Hospital Bath NHS Trust
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history